GLP-1 Health Information: Quality, Completeness, & Engagement

Key Points

• A study assessed 128 GLP-1-related videos from Douyin and Bilibili.
• Longer videos generally received higher scores for information quality and transparency.
• Likes, comments, and other engagement metrics did not consistently indicate quality.
• Bilibili videos showed higher scores on some reliability measures than Douyin videos.
• The study highlights the need to carefully evaluate social media health information.
• For More Updates, Explore all Endocrinology CME Conferences & Online Courses

GLP-1 health information is increasingly available on social media, but popularity may not indicate reliability. A recent study in Therapeutic Advances in Endocrinology and Metabolism evaluated GLP-1 receptor agonist content on Douyin and Bilibili to examine information quality, completeness, and factors associated with higher-quality content.

What Did the Study Find About GLP-1 Health Information?

Researchers reviewed publicly available videos containing the keyword “GLP1.” After applying predefined exclusion criteria, the final sample included 128 videos: 56 from Douyin and 72 from Bilibili.

The platforms differed in both video length and publisher type. More than half of the Bilibili videos exceeded 300 seconds, compared with 16.1% of Douyin videos. Doctors produced 66.1% of the sampled Douyin videos, while personal users produced 58.3% of the Bilibili videos.

Researchers assessed content using modified DISCERN, Global Quality Score (GQS), and JAMA benchmarks. They also examined six areas of educational completeness, including mechanisms, indications, contraindications, use, adverse effects, and treatment outcomes.

Bilibili videos achieved higher mean modified DISCERN and JAMA scores than Douyin videos, although the study found no significant difference in GQS scores. Bilibili also showed greater content completeness across the six assessed dimensions.

Can Social Media Engagement Show Medical Information Quality?

The findings suggest that engagement metrics such as likes and comments should not serve as stand-alone indicators of reliable medical information.

Video duration showed a stronger relationship with researcher-rated quality. Across the three duration categories, longer videos generally received higher modified DISCERN, GQS, and JAMA scores. On Bilibili, duration was the only measured factor associated with all three quality measures.

The study also identified five videos promoting or selling products described as counterfeit GLP-1 products. However, researchers did not perform laboratory testing to confirm the contents of those products.

For More Updates, Explore all Endocrinology CME Conferences & Online Courses

For healthcare professionals, these findings reinforce the importance of assessing authorship, references, transparency, completeness, potential conflicts of interest, and clinical context when reviewing GLP-1 health information online. The researchers noted that their scoring tools assessed characteristics of information quality and reliability rather than independently verifying every medical claim.

What Should HCPs Know About GLP-1 Social Media Content?

The study provides a snapshot of GLP-1-related content on two Chinese social media platforms and cannot establish that one platform is inherently more reliable than the other. Differences in sampling methods, the cross-sectional design, and the exclusion criteria also limit broader conclusions.

The findings support greater attention to digital health literacy and responsible health communication as interest in GLP-1 receptor agonists continues to grow. For clinicians and nurses, social media popularity alone may offer limited insight into the clinical reliability of medication-related content.

Source:

Sage Journals